Emily DiMango

7.7k total citations · 1 hit paper
70 papers, 3.3k citations indexed

About

Emily DiMango is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Emily DiMango has authored 70 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 9 papers in Surgery. Recurrent topics in Emily DiMango's work include Cystic Fibrosis Research Advances (29 papers), Asthma and respiratory diseases (23 papers) and Respiratory and Cough-Related Research (10 papers). Emily DiMango is often cited by papers focused on Cystic Fibrosis Research Advances (29 papers), Asthma and respiratory diseases (23 papers) and Respiratory and Cough-Related Research (10 papers). Emily DiMango collaborates with scholars based in United States, Canada and United Kingdom. Emily DiMango's co-authors include Alice Prince, Ruth Bryan, Heather J. Zar, Robert F. Lemanske, Adam J. Ratner, Claire Keating, Setareh Tabibi, Michael J. Gambello, Joanna B. Goldberg and Elliot Israel and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Emily DiMango

65 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

2020 501 citations Kathryn Blake, Emily DiMango et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily DiMango United States	27	1.8k	1.3k	829	427	257	70	3.3k
James F. Chmiel United States	36	3.0k 1.7×	1.2k 0.9×	800 1.0×	529 1.2×	211 0.8×	81	4.4k
Louise Fleming United Kingdom	31	2.1k 1.2×	2.5k 2.0×	480 0.6×	445 1.0×	243 0.9×	101	3.6k
Marie-Christine Dombret France	19	1.2k 0.7×	1.1k 0.9×	768 0.9×	544 1.3×	219 0.9×	28	3.0k
Yvonne J. Huang United States	24	1.3k 0.7×	902 0.7×	1.7k 2.0×	236 0.6×	160 0.6×	51	3.0k
Patrick Lebecque Belgium	31	1.9k 1.1×	718 0.6×	448 0.5×	102 0.2×	261 1.0×	99	3.0k
Yves Sibille Belgium	29	1.6k 0.9×	773 0.6×	603 0.7×	965 2.3×	337 1.3×	79	3.7k
Harriet Corvol France	34	2.0k 1.1×	380 0.3×	721 0.9×	330 0.8×	314 1.2×	148	3.1k
Peter Oluf Schiøtz Denmark	31	754 0.4×	515 0.4×	397 0.5×	654 1.5×	169 0.7×	100	2.3k
Anthony De Soyza United Kingdom	40	4.3k 2.4×	675 0.5×	597 0.7×	383 0.9×	532 2.1×	204	5.6k
Frans De Baets Belgium	27	1.0k 0.6×	328 0.3×	431 0.5×	112 0.3×	154 0.6×	89	1.9k

Countries citing papers authored by Emily DiMango

Since Specialization

Citations

This map shows the geographic impact of Emily DiMango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily DiMango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily DiMango more than expected).

Fields of papers citing papers by Emily DiMango

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily DiMango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily DiMango. The network helps show where Emily DiMango may publish in the future.

Co-authorship network of co-authors of Emily DiMango

This figure shows the co-authorship network connecting the top 25 collaborators of Emily DiMango. A scholar is included among the top collaborators of Emily DiMango based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily DiMango. Emily DiMango is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

George, Maureen, Emily DiMango, Jean‐Marie Bruzzese, et al.. (2025). Feasibility of Home Air Quality Monitoring in Homes of Black Adults Living in New York City Receiving Care for Uncontrolled Asthma in a Federally Qualified Health Center. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3148–A3148.

Konstan, Michael W., James Tolle, Emily DiMango, et al.. (2025). A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis. Clinical Pharmacokinetics. 64(10). 1561–1574.

Leonard, Amanda, Julianna Bailey, Amanda S. Bruce, et al.. (2023). Nutritional considerations for a new era: A CF foundation position paper. Journal of Cystic Fibrosis. 22(5). 788–795. 31 indexed citations

Gifford, Alex H., Shijing Jia, Samya Z. Nasr, et al.. (2023). Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis. CHEST Journal. 164(3). 614–624. 3 indexed citations

DiMango, Emily, et al.. (2021). Health Disparities among adults cared for at an urban cystic fibrosis program. Orphanet Journal of Rare Diseases. 16(1). 332–332. 10 indexed citations

Maćešić, Nenad, Jennifer Laplante, Justin G. Aaron, et al.. (2020). Baloxavir treatment of oseltamivir‐resistant influenza A/H1pdm09 in two immunocompromised patients. Transplant Infectious Disease. 23(3). e13542–e13542. 10 indexed citations

McKone, Edward F., Emily DiMango, Sivagurunathan Sutharsan, et al.. (2020). A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation. Journal of Cystic Fibrosis. 20(2). 234–242. 11 indexed citations

Bose, Sonali, Christian Bime, Robert J. Henderson, et al.. (2020). Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST). The Journal of Allergy and Clinical Immunology In Practice. 8(10). 3474–3481. 7 indexed citations

Lozano, Carmen, Ahmed M. Moustafa, Kira L. Tomlinson, et al.. (2019). CFTR-PTEN–dependent mitochondrial metabolic dysfunction promotes Pseudomonas aeruginosa airway infection. Science Translational Medicine. 11(499). 71 indexed citations

10.

DiMango, Emily, Mariana Bucovsky, Sanchita Agarwal, et al.. (2018). Abnormal microarchitecture and stiffness in postmenopausal women using chronic inhaled glucocorticoids. Osteoporosis International. 29(9). 2121–2127. 12 indexed citations

11.

Nishiyama, Kyle K., Sanchita Agarwal, Anna Kepley, et al.. (2017). Adults with cystic fibrosis have deficits in bone structure and strength at the distal tibia despite similar size and measuring standard and relative sites. Bone. 107. 181–187. 14 indexed citations

12.

DiMango, Emily, Denise Serebrisky, Chang Shim, et al.. (2016). Individualized Household Allergen Intervention Lowers Allergen Level But Not Asthma Medication Use: A Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology In Practice. 4(4). 671–679.e4. 52 indexed citations

13.

Keating, Claire, Xinhua Liu, Codruța Chiuzan, et al.. (2016). Reduced survival in adult cystic fibrosis despite attenuated lung function decline. Journal of Cystic Fibrosis. 16(1). 78–84. 21 indexed citations

14.

Sheares, Beverley J., Robert B. Mellins, Emily DiMango, et al.. (2015). Do Patients of Subspecialist Physicians Benefit from Written Asthma Action Plans?. American Journal of Respiratory and Critical Care Medicine. 191(12). 1374–1383. 39 indexed citations

15.

Robinson, N. Bryce & Emily DiMango. (2014). Prevalence of Gastroesophageal Reflux in Cystic Fibrosis and Implications for Lung Disease. Annals of the American Thoracic Society. 11(6). 964–968. 46 indexed citations

16.

DiMango, Emily, Patricia Walker, Claire Keating, et al.. (2014). Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis. BMC Pulmonary Medicine. 14(1). 21–21. 38 indexed citations

17.

DiMango, Emily, Janet T. Holbrook, Joan Reibman, et al.. (2009). Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on Asthma Severity. American Journal of Respiratory and Critical Care Medicine. 180(9). 809–816. 40 indexed citations

18.

Deykin, Aaron, Michael E. Wechsler, Homer A. Boushey, et al.. (2006). Combination Therapy with a Long-Acting β-Agonist and a Leukotriene Antagonist in Moderate Asthma. American Journal of Respiratory and Critical Care Medicine. 175(3). 228–234. 53 indexed citations

19.

DiMango, Emily, et al.. (2005). Results of a Culturally Directed Asthma Intervention Program in an Inner-city Latino Community. CHEST Journal. 128(3). 1163–1167. 18 indexed citations

20.

Wechsler, Michael E., Erik Lehman, Stephen C. Lazarus, et al.. (2005). β-Adrenergic Receptor Polymorphisms and Response to Salmeterol. American Journal of Respiratory and Critical Care Medicine. 173(5). 519–526. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact